Brief: Ironwood Pharmaceuticals Q3 Revenue USD 113.739 Million Vs. IBES Estimate USD 112.9 Million
09/11/2023 12:00
Nov 09 (Reuters) - Ironwood Pharmaceuticals Q3 adjusted net income USD 21.802 million. * Q3 net income USD 13.95 million * Q3 adjusted EBITDA USD 49.079 million * Q3 operating expenses USD 73.716 million
Recent news on Ironwood Pharmaceuticals
See all newsBrief: Ironwood Pharmaceuticals Appoints Tammi Gaskins As Chief Executive Officer
Ironwood Pharmaceuticals, Inc. reports results for the quarter ended June 30 - Earnings Summary
Ironwood Q2 revenue rises 33%
Brief: Ironwood Pharmaceuticals Repaid In Full $200 Million 1.5% Convertible Senior Notes Due 2026
Brief: FDA Approves Use Of Linzess In Pediatric Patients Aged 2 & Older With Functional Constipation